well as to utilize more challenging classes of diazo reagents
for use in asymmetric cyclopropanation.
In contrast to the large body of excellent results
achieved with diazoacetates,1-3 diazoacetamides have not
been successfully employed for asymmetric intermolecular
cyclopropanation (Scheme 1)4 except for the Rh2-based
1 with excellent diastereo- and enantioselectivities. As a
result of the highly reactive hydroxysuccinimide esters
present, 1 could serve as convenient synthons for the general
preparation of chiral amides 2 through reactions with a range
of different amines and without loss of pre-established
enantiomeric purity.
Structurally well-defined cobalt(II) complexes of D2-
symmetric chiral porphyrins ([Co(Por*)]) have emerged as
a class of effective catalysts for asymmetric cyclopropanation
reactions,11-13 with both electron-sufficient12a,b and electron-
deficient12c olefins using diazoacetates,12b,c diazosulfones,12d
and R-nitro diazoacetates.12e Among this family of [Co-
(Por*)],12 a group of six derivatives [Co(P1)]-[Co(P6)]
(Figures 1 and S1 (Supporting Information)), possessing
Scheme 1. Routes to Chiral Cyclopropyl Carboxamides
intramolecular reactions by Doyle and co-workers.5,6 The
absence of effective intermolecular asymmetric cyclopropa-
nation with diazoacetamides may be attributed to two major
factors: (i) inherent low reactivity of the resulting metal-
carbene intermediate due to reduced electrophilicity and
increased steric hindrance and (ii) complications resulting
from competitive intramolecular C-H insertion.7 Inspired
by their important biomedical applications,8 we envisioned
a postderivatization approach to synthesize chiral cyclopropyl
carboxamides 2 in enantioenriched form through reacting
preformed cyclopropyl chiral building blocks 1 with various
amines (Scheme 1).9 Herein, we report a cobalt-catalyzed
asymmetric cyclopropanation process with succinimidyl
diazoacetate (N2CHCO2Su),10 which forms cyclopropanes
Figure 1. D2-Symmetric chiral cobalt(II) porphyrins.
diverse electronic, steric, and chiral environments, were
evaluated as potential catalysts for the asymmetric cyclo-
propanation of styrene with the sterically bulky N2CHCO2Su
(Table 1). As a practical attribute of [Co(Por)]-catalyzed
cyclopropanation,14a these reactions were carried out in a
one-pot fashion with alkene as limiting reagent and without
the occurrence of the common dimerization side reaction.
Upon examination of the results (Table 1), it was evident
that the steric bulkiness of the carbene source governed the
reactivity difference of these catalysts. For example, no
(4) For nonasymmetric cyclopropanation with R-diazoacetamides, see:
(a) Doyle, M. P.; Dorow, R. L.; Terpstra, J. W.; Rodenhouse, R. A. J. Org.
Chem. 1985, 50, 1663. (b) Jeganathan, A.; Richardson, S. K.; Mani, R. S.;
Haley, B. E.; Watt, D. S. J. Org. Chem. 1986, 51, 5362. (c) Doyle, M. P.;
Loh, K.-L.; DeVries, K. M.; Chinn, M. S. Tetrahedron Lett. 1987, 28, 833.
(d) Haddad, N.; Galili, N. Tetrahedron: Asymmetry 1997, 8, 3367. (e) Gross,
Z.; Galili, N.; Simkhovich, L. Tetrahedron Lett. 1999, 40, 1571. (f)
Muthusamy, S.; Gunanathan, C. Synlett 2003, 1599.
(5) (a) Doyle, M. P.; Austin, R. E.; Bailey, A. S.; Dwyer, M. P.; Dyatkin,
A. B.; Kalinin, A. V.; Kwan, M. M. Y.; Liras, S.; Oalmann, C. J.; Pieters,
R. J.; Protopopova, M. N.; Raab, C. E.; Roos, G. H. P.; Zhou, Q.-L.; Martin,
S. F. J. Am. Chem. Soc. 1995, 117, 5763. (b) Doyle, M. P.; Kalinin, A. V.
J. Org. Chem. 1996, 61, 2179. (c) Doyle, M. P.; Eismont, M. Y.;
(9) For an example of ineffective asymmetric cyclopropanation directly
with diazoacetamides by current Co(II)-based catalytsts, see Scheme S1,
Supporting Information.
(10) The solid N2CHCO2Su, which is stable and can be handled safely,
has not been previously employed for asymmetric cyclopropanation. For a
single report on Ru-catalyzed nonasymmetric cyclopropanation with
N2CHCO2Su, see: (a) Werle, T.; Maas, G. AdV. Synth. Catal. 2001, 343,
37. For the use of N2CHCO2Su to synthesize diazo derivatives, see: (b)
Ouihia, A.; Rene, L.; Guilhem, J.; Pascard, C.; Badet, B. J. Org. Chem.
1993, 58, 1641. (c) Fuerst, D. E.; Stoltz, B. M.; Wood, J. L. Org. Lett.
2000, 2, 3521. (d) Clark, J. P.; Middleton, M. D. Org. Lett. 2002, 4, 765.
(e) Grohmann, M.; Buck, S.; Schaffler, L.; Maas, G. AdV. Synth. Catal.
2006, 348, 2203. (f) Reference 5.
Protopopova, M. N.; Kwan, M. M. Y. Tetrahedron 1994, 50, 1665
.
(6) For a recent exmple on asymmetric cyclopropanation of R-ami-
dodiazoacetates, see: Marcoux, D.; Charette, A. B. Agnew. Chem. Int. Ed.
2008, 47, 10155
.
(7) For select examples of intramolecular carbene C-H insertion of
R-diazoacetamides, see: (a) Brown, D. S.; Elliott, M. C.; Moody, C. J.;
Mowlem, T. J.; Marino, J. P.; Padwa, A. P. J. Org. Chem. 1994, 59, 2447.
(b) Gois, P. M. P.; Afonso, C. A. M. Eur. J. Org. Chem. 2004, 3773. (c)
Grohmann, M.; Buck, S.; Schaffler, L.; Maas, G. AdV. Synth. Catal. 2006,
348, 2203.
(11) Doyle, M. P. Agnew. Chem. Int. Ed. 2009, 48, 850
.
(12) (a) Chen, Y.; Fields, K. B.; Zhang, X. P. J. Am. Chem. Soc. 2004,
126, 14718. (b) Chen, Y.; Zhang, X. P. J. Org. Chem. 2007, 72, 5931. (c)
Chen, Y.; Ruppel, J. V.; Zhang, X. P. J. Am. Chem. Soc. 2007, 129, 12074.
(d) Zhu, S.; Ruppel, J. V.; Lu, H.; Wojtas, L.; Zhang, X. P. J. Am. Chem.
Soc. 2008, 130, 5042. (e) Zhu, S.; Perman, J. A.; Zhang, X. P. Agnew.
(8) For select recent examples, see: (a) Garrido, D. M.; Corbett, D. F.;
Dwornik, K. A.; Goetz, A. S.; Littleton, T. R.; McKeown, S. C.; Mills,
W. Y.; Smalley, T. L.; Briscore, C. P.; Peat, A. J. Bioorg. Med. Chem.
Lett. 2006, 16, 1840. (b) Jiang, T.; Kuhen, K. L.; Wolff, K.; Yin, H.; Bieza,
K.; Caldwell, J.; Bursulaya, B.; Wu, T. Y.-H.; He, Y. Bioorg. Med. Chem.
Lett. 2006, 16, 2105. (c) Sandanayaka, V. P.; Prashad, A. S.; Yang, Y.;
Williamson, T.; Lin, Y. I.; Mansour, T. S. J. Med. Chem. 2003, 46, 2569.
(d) Morain, P.; Lestage, P.; De Nanteuil, G.; Jochemsen, R.; Robin, J.-L.;
Guez, D.; Boyer, P.-A. CNS Drug ReV. 2002, 8, 31. (e) Graham, D. W.;
Ashton, W. T.; Barash, L.; Brown, J. E.; Brown, R. D.; Canning, L. F.;
Chen, A.; Springer, J. P.; Rogers, E. F. J. Med. Chem. 1987, 30, 1074.
Chem. Int. Ed. 2008, 47, 8460
.
(13) For other contributions on [Co(Por)]-catalyzed cyclopropanation,
see: (a) Penoni, A.; Wanke, R.; Tollari, S.; Gallo, E.; Musella, D.; Ragaini,
F.; Demartin, F.; Cenini, S. Eur. J. Inorg. Chem. 2003, 1452. (b) Caselli,
A.; Gallo, E.; Ragaini, F.; Ricatto, F.; Abbiati, G.; Cenini, S. Inorg. Chim.
Acta 2006, 359, 2924. (c) Fantauzzi, S.; Gallo, E.; Rose, E.; Raoul, N.;
Caselli, A.; Issa, S.; Ragaini, F.; Cenini, S. Organometallics 2008, 27, 6143
.
2274
Org. Lett., Vol. 11, No. 11, 2009